Skip to main content
Back
Watch Compare

Medicus Pharma Ltd.

Data quality: 83%
Also listed as MDCXW NASDAQ
MDCX
NASDAQ Manufacturing Chemicals
$0.31
▲ $0.01 (3.11%)
6 months return
—
Momentum
Neutral
ROE
-4043.60%

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-4043.60%
Below sector avg (-54.47%)
ROIC-2003.07%
Net MarginN/A
Op. MarginN/A

Safety

Debt / Equity
N/A
Current Ratio0.92
Interest Coverage-174.08

Valuation

PE (TTM|NTM)
-0.34 | -0.75
Above sector avg (-1.50)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Negative free cash flow of -22.78 M

Price History

Financial Trends

Analyst Price Target

4 analysts
Buy
+3281.2%
upside to target
Current
$0.31
Consensus Target
$10.53
$6.00
Low
$21.13
High
Forecast
Forward P/E
-0.75
Forward EPS
-$0.51
Est. Revenue
0.0

Earnings Surprises

EPS
Reported Estimate Forecast
Next: Q1 2026 · EPS Est: -$0.22 · Rev Est: 0.0
Q12025 Q22025 Q32025 Q42025 Q1 '26 Q2 '26
Reported -$0.42 -$0.42 -$1.09 -$0.44 — —
Estimate -$0.22 -$0.27 -$0.38 -$0.36 -$0.22 -$0.17
Surprise -95.35% -57.89% -187.71% -25.13% — —

Growth

Rev 5Y: N/A · Earnings 1Y: N/A
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A

Profitability

ROE: -4043.60% · Net Margin: N/A
Revenue (TTM) N/A Net Income (TTM) -47.28 M
ROE -4043.60% ROA -431.55%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -22.78 M
ROIC -2003.07% FCF Growth (3Y) N/A

Safety

D/E: N/A · Current: 0.92
Debt / Equity N/A Current Ratio 0.92
Interest Coverage -174.08 Asset Turnover N/A
Working Capital -876,489 Tangible Book Value -910,126

Dividends

Yield: N/A · Payout: N/A
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A

Valuation

P/E: -0.34 · EV/EBITDA: N/A
P/E Ratio -0.34 Forward P/E -0.75
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -139.77%
Market Cap 16.30 M Enterprise Value 7.63 M

Per Share

EPS: -2.74 · FCF/Share: -0.58
EPS (Diluted TTM) -2.74 Revenue / Share N/A
FCF / Share -0.58 OCF / Share -0.58
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A

Efficiency

FCF Conv: 48.17% · CapEx/Rev: N/A
CapEx / Revenue N/A FCF Conversion 48.17%
SBC-Adj. FCF -24.29 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024
Revenue — —
Net Income -47.28 M -11.16 M
EPS (Diluted) -2.74 -1.16
Gross Profit — —
Operating Income -34.36 M -11.18 M
EBITDA — —
R&D Expenses 7.72 M 3.53 M
SG&A Expenses — —
D&A — —
Interest Expense -197,382.0 —
Income Tax 0.0 0.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024
Total Assets 10.06 M 5.65 M
Total Liabilities 10.02 M 2.51 M
Shareholders' Equity -67,554.0 3.13 M
Total Debt — —
Cash & Equivalents 8.71 M 4.16 M
Current Assets 9.89 M 5.38 M
Current Liabilities 9.94 M 2.31 M

Peer Comparison

vs Manufacturing sector median (1605 peers)
Metric Stock Sector Median
P/E -0.3 -1.5
P/B — 1.6
ROE % -4043.6 -54.5
Net Margin % — -41.5
Rev Growth 5Y % — 1.9
D/E — 0.3